CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
82 hedge funds and large institutions have $70.5M invested in CureVac in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 19 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 16
106% more call options, than puts
Call options by funds: $4.37M | Put options by funds: $2.12M
25% more capital invested
Capital invested by funds: $56.4M → $70.5M (+$14.1M)
2.4% more ownership
Funds ownership: 3.81% → 6.21% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
1% less funds holding
Funds holding: 83 → 82 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.09M |
| 4 |
Millennium Management
New York
|
+$2.44M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$1.74M |
| 2 |
Goldman Sachs
New York
|
-$1.26M |
| 3 |
Renaissance Technologies
New York
|
-$783K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$776K |
| 5 |
GF
Gates Foundation
Seattle,
Washington
|
-$619K |
CVAC Hedge Fund Activity: Q4 2022 in Review
82 institutional investors reported a position in CureVac (CVAC) for Q4 2022, worth a combined $70.5M — up 25% from $56.4M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CVAC and 18 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 36 added.
The largest buyer was Citadel Advisors, adding an estimated $14.1M. The largest seller was Man Group, cutting an estimated $1.74M.
- 82 institutional investors held CureVac (CVAC) as of Q4 2022, down from 83 in Q3 2022.
- Funds reported $70.5M of CureVac stock for Q4 2022, up 25% quarter-over-quarter.
- 18 funds opened new CureVac positions in Q4 2022 and 19 closed out, a net change of -1 holder.
- The largest CureVac buyer in Q4 2022 was Citadel Advisors, an estimated $14.1M added.
- The largest CureVac seller in Q4 2022 was Man Group, an estimated $1.74M sold.
Based on aggregated 13F filings for Q4 2022.